News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amexdrug Corp. (AXRX) Unveils New Product Line



3/21/2007 1:11:43 PM

BEVERLY HILLS, CA -- (MARKET WIRE) -- March 21, 2007 -- Amexdrug Corporation (OTCBB: AXRX) today announced that it has completed formulation and market analysis, and has moved on to the initial production phase of its new line of five over-the-counter products aimed at fungal infections, brittle nails, as well as a topical analgesic. These over-the-counter natural products will be manufactured using all FDA-approved ingredients through Amexdrug's subsidiary Dermagen, Inc., and will be sold and marketed through another Amexdrug subsidiary, BioRX Pharmaceuticals.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES